27
Participants
Start Date
October 31, 2006
Primary Completion Date
June 30, 2009
Study Completion Date
January 31, 2012
MKC-1
capsules, twice daily for 14 days in 21 day cycle
pemetrexed
standard dosing of 500 mg/m2 infused every 21 days
Indiana University Cancer Center, Indianapolis
University of Iowa, Iowa City
University of Wisconsin Hospital and Clinics, Madison
Swedish Cancer Institute, Seattle
Lead Sponsor
CASI Pharmaceuticals, Inc.
INDUSTRY